Androgen Receptor Promotes Abdominal Aortic Aneurysm Development via Modulating Inflammatory Interleukin-1α and Transforming Growth Factor-β1 Expression. Issue 4 (October 2015)
- Record Type:
- Journal Article
- Title:
- Androgen Receptor Promotes Abdominal Aortic Aneurysm Development via Modulating Inflammatory Interleukin-1α and Transforming Growth Factor-β1 Expression. Issue 4 (October 2015)
- Main Title:
- Androgen Receptor Promotes Abdominal Aortic Aneurysm Development via Modulating Inflammatory Interleukin-1α and Transforming Growth Factor-β1 Expression
- Authors:
- Huang, Chiung-Kuei
Luo, Jie
Lai, Kuo-Pao
Wang, Ronghao
Pang, Haiyan
Chang, Eugene
Yan, Chen
Sparks, Janet
Lee, Soo Ok
Cho, Joshua
Chang, Chawnshang - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p>Sex difference is a risk factor for abdominal aortic aneurysm (AAA) formation yet the reason for male predominance remains unclear. Androgen and the androgen receptor (AR) influence the male sex difference, indicating that AR signaling may affect AAA development. Using angiotensin II–induced AAA in apolipoprotein E null mouse models (82.4% AAA incidence), we found that mice lacking AR failed to develop AAA and aorta had dramatically reduced macrophages infiltration and intact elastic fibers. These findings suggested that AR expression in endothelial cells, macrophages, or smooth muscle cells might play a role in AAA development. Selective knockout of AR in each of these cell types further demonstrated that mice lacking AR in macrophages (20% AAA incidence) or smooth muscle cells (12.5% AAA incidence) but not in endothelial cells (71.4% AAA incidence) had suppressed AAA development. Mechanism dissection showed that AR functioned through modulation of interleukin-1α (IL-1α) and transforming growth factor-β1 signals and by targeting AR with the AR degradation enhancer ASC-J9 led to significant suppression of AAA development. These results demonstrate the underlying mechanism by which AR influences AAA development is through IL-1α and transforming growth factor-β1, and provides a potential new therapy to suppress/prevent AAA by targeting AR with ASC-J9.</p> </sec> </abstract>
- Is Part Of:
- Hypertension. Volume 66:Issue 4(2015:Oct.)
- Journal:
- Hypertension
- Issue:
- Volume 66:Issue 4(2015:Oct.)
- Issue Display:
- Volume 66, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 66
- Issue:
- 4
- Issue Sort Value:
- 2015-0066-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-10
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Treatment -- Periodicals
616.132005 - Journal URLs:
- http://hyper.ahajournals.org ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/HYPERTENSIONAHA.115.05654 ↗
- Languages:
- English
- ISSNs:
- 0194-911X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4352.629000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3141.xml